Cortes J, Priego A, Garralda E, Rojas K, et al. A First-in-Class mAb (BI-1607) Targeting FcgammaRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors. Clin Cancer Res 2025;31:4953-4963.
PMID: 41071338